Sugammadex Fresenius i.v. 200 mg/2 ml
Sugammadex Fresenius i.v. 200 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 69703. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 November 2024 and the authorisation is limited until 14 November 2029. ATC code V03AB35 places the medicine in the group All other therapeutic products.
| Authorisation number | 69703 |
|---|---|
| Name | Sugammadex Fresenius i.v. 200 mg/2 ml |
| Full name | Sugammadex Fresenius i.v. 200 mg/2 ml, Injektionslösung |
| Authorisation holder | Fresenius Kabi (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | V03AB35 |
| First authorisation | 15 November 2024 |
| Authorisation validity | 14 November 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Sugammadex Fresenius i.v. 200 mg/2 ml, Injektionslösung | B | 15 November 2024 |
| 3 | Sugammadex Fresenius i.v. 500 mg/5 ml, Injektionslösung | B | 15 November 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Durchstechflasche(n) | V03AB35 | 15.01.0. | B |
| 2 | 10 | Durchstechflasche(n) | V03AB35 | 15.01.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sugammadex Fresenius i.v. 200 mg/2 ml authorised in Switzerland?
Yes. Sugammadex Fresenius i.v. 200 mg/2 ml is authorised by Swissmedic under authorisation number 69703, data as of 01 September 2026. The authorisation is limited until 14 November 2029.
Which dispensing category does Sugammadex Fresenius i.v. 200 mg/2 ml have?
Sugammadex Fresenius i.v. 200 mg/2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sugammadex Fresenius i.v. 200 mg/2 ml?
The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.